IL1B and type 2 diabetes mellitus: In this context, our study demonstrated that treatment of type 2 diabetic rats with FA for 28 days significantly downregulated hepatic and renal levels of key pro-inflammatory mediators – including NF-κB-p65, IL-1β, and IL-6 – compared to untreated diabetic rats.